Respiratory Medicine
Volume 104, Issue 5 , Pages 668-674 , May 2010

Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: A randomised controlled trial

  • Duncan B. Richards

      Affiliations

    • Drug Discovery, GlaxoSmithKline, Stevenage CB2 2GG, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1223 296159.
    • ,
  • Philippe Bareille

      Affiliations

    • Drug Discovery, GlaxoSmithKline, Stevenage CB2 2GG, UK
    • ,
  • Emma L. Lindo

      Affiliations

    • Discovery Biometrics, GlaxoSmithKline, Greenford, UK
    • ,
  • Dean Quinn

      Affiliations

    • P3 Research, Bowen Hospital, Wellington, New Zealand
    • ,
  • Stuart N. Farrow

      Affiliations

    • Drug Discovery, GlaxoSmithKline, Stevenage CB2 2GG, UK

Received 23 July 2009 ,Accepted 10 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(09)00370-9

doi: 10.1016/j.rmed.2009.11.006

Respiratory Medicine
Volume 104, Issue 5 , Pages 668-674 , May 2010

Article Tools

* Image Usage & Resolution